Clinical trial register · Taiwan

Clinical Trials in Taichung, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2875 matching records held by the registry are in this view. Synced 31 Oct 2026, 03:19 UTC

2875

Studies in scope

all four open statuses

1576

Recruiting now

open to new participants

341

Lead sponsors

across recruiting studies

Top sites

Kaohsiung City 2 Taichung 2 Taipei 2 Chang-hua 1 Tainan 1

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site location

All 5 locations

Target enrolment

Trials with a site in Taichung

Status

Study

Lead sponsor

Phase

Enrol

Sites in Taiwan

Start

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

NCT07185997Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer, Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing

DrugFurmonertinib

ArriVent BioPharma, Inc.

Phase 3

480

Kaohsiung City, Taichung, Taipei

2025-12-17

Active, closed

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

NCT05607550Metastatic Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, EGFR Exon 20 Mutations

DrugFurmonertinib

ArriVent BioPharma, Inc.

Phase 3

398

Chang-hua, Kaohsiung City, Taichung, Tainan, Taipei

2023-06-01

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-taiwan/city/taichung

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,875 studies in total at the last sync on 31 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Taichung that also match the filters currently applied.

How many clinical trials are recruiting in Taichung?

1 of the 2 studies on this page are recruiting new participants as of the 31 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Taichung), 2 studies
Phase	Studies	Recruiting	Share
Phase 3	2	1	100%

Most active sponsors

Lead sponsors with the most studies (Taichung)
Lead sponsor	Studies	Recruiting
ArriVent BioPharma, Inc.	2	1

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.